State Of Tennessee, Treasury Department Ligand Pharmaceuticals Inc Transaction History

State Of Tennessee, Treasury Department

$27.8 Billion
Q3 2024

A detailed history of State Of Tennessee, Treasury Department transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 7,180 shares of LGND stock, worth $880,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,180

Previous 7,434 3.42%

Holding current value

$880,986

Previous $626,000 14.86%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$82.7 - $110.11 $21,005 - $27,967	-254 Reduced 3.42%	7,180 $719,000
Q2 2024 Aug 13, 2024	SELL	$68.53 - $87.91 $140,006 - $179,600	-2,043 Reduced 21.56%	7,434 $626,000
Q1 2024 May 14, 2024	SELL	$68.64 - $89.2 $73,238 - $95,176	-1,067 Reduced 10.12%	9,477 $692,000
Q4 2023 Feb 14, 2024	SELL	$49.57 - $72.63 $49,867 - $73,065	-1,006 Reduced 8.71%	10,544 $753,000
Q2 2023 Aug 15, 2023	BUY	$69.53 - $79.33 $66,679 - $76,077	959 Added 9.05%	11,550 $832,000
Q1 2023 May 12, 2023	SELL	$65.67 - $77.08 $71,777 - $84,248	-1,093 Reduced 9.35%	10,591 $779,000
Q3 2022 Jan 26, 2023	BUY	$0.01 - $107.56 $6 - $74,861	696 Added 6.33%	11,684 $1.01 Million
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $5,141 - $8,077	-69 Reduced 0.62%	10,988 $980,000
Q1 2022 May 11, 2022	BUY	$94.99 - $151.56 $166,897 - $266,290	1,757 Added 18.89%	11,057 $1.24 Million
Q4 2021 Feb 15, 2022	SELL	$127.69 - $165.85 $22,984 - $29,853	-180 Reduced 1.9%	9,300 $1.44 Million
Q3 2021 Nov 12, 2021	BUY	$102.33 - $144.73 $277,314 - $392,218	2,710 Added 40.03%	9,480 $1.32 Million
Q1 2021 May 10, 2021	SELL	$99.52 - $215.83 $55,830 - $121,080	-561 Reduced 7.65%	6,770 $1.03 Million
Q4 2020 Feb 09, 2021	SELL	$80.55 - $106.05 $1.58 Million - $2.09 Million	-19,669 Reduced 72.85%	7,331 $729,000
Q2 2020 Aug 13, 2020	BUY	$68.28 - $123.65 $1.84 Million - $3.34 Million	27,000 New	27,000 $3.02 Million
Q3 2019 Oct 30, 2019	SELL	$86.25 - $120.16 $1.6 Million - $2.23 Million	-18,522 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$107.38 - $129.34 $180,505 - $217,420	-1,681 Reduced 8.32%	18,522 $2.11 Million
Q4 2018 Feb 11, 2019	BUY	$128.36 - $272.13 $818,038 - $1.73 Million	6,373 Added 46.08%	20,203 $2.74 Million
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $117,204 - $152,341	-555 Reduced 3.86%	13,830 $3.8 Million
Q2 2018 Aug 14, 2018	SELL	$150.77 - $207.98 $75,837 - $104,613	-503 Reduced 3.38%	14,385 $2.98 Million
Q1 2018 May 11, 2018	SELL	$138.63 - $182.62 $216,817 - $285,617	-1,564 Reduced 9.51%	14,888 $2.46 Million
Q4 2017 Feb 12, 2018	SELL	$128.36 - $147.04 $38,508 - $44,112	-300 Reduced 1.79%	16,452 $2.25 Million
Q3 2017 Nov 01, 2017	BUY	$120.91 - $137.94 $2.03 Million - $2.31 Million	16,752	16,752 $2.28 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.

Account

State Of Tennessee, Treasury Department Ligand Pharmaceuticals Inc Transaction History